| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00042 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.00038 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.00034 | 1 |